VITAS delivered strong Q2 2026 results, driving higher revenue and margins, while Roto-Rooter maintained stable performance despite increased marketing costs. Full-year guidance was raised for VITAS, with robust cash flow supporting acquisitions and share repurchases.Based on Chemed Corp [CHE] Q2 2…
Healthcare services company Chemed Corporation NYSE:CHE reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.8% year on year to $673.3 million. Its non-GAAP profit of $6.06 per share was 8.2% above analysts’ consensus estimates.Chemed (CHE) Q2 CY2026 Highlights:Company…
CHE (Chemed Corp) is set to announce its Q2'26 results on July 28, after the market closes. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).For Q2'26, revenue estimate is 665.04 million USD with EPS (earnings per share) anticipated at 5.60 USD. Learn more details at CHE Financ…
Healthcare services company Chemed Corporation NYSE:CHEwill be reporting earnings this Tuesday after market close. Here’s what to look for.Chemed beat analysts’ revenue expectations last quarter, reporting revenues of $657.5 million, up 1.6% year on year. It was a strong quarter for the company, wi…
